• 1. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 2. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 3. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 4. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 5. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzenes

Professional Introduction to 1-Bromo-3,5-dimethyl-2-nitrobenzene (CAS No. 78831-77-3)

1-Bromo-3,5-dimethyl-2-nitrobenzene, identified by the Chemical Abstracts Service (CAS) number 78831-77-3, is a significant intermediate in the realm of organic synthesis and pharmaceutical chemistry. This compound, characterized by its bromo and nitro substituents on a dimethylated benzene ring, has garnered attention due to its versatile reactivity and potential applications in the development of novel chemical entities. The structural motif of this molecule, featuring a nitro group at the 2-position and bromine atoms at the 3 and 5 positions, makes it a valuable precursor for further functionalization, enabling access to a diverse array of derivatives with tailored properties.

The synthesis of 1-Bromo-3,5-dimethyl-2-nitrobenzene typically involves a multi-step process that begins with the nitration of m-xylene, followed by selective bromination. The nitration step introduces the nitro group at the 2-position through electrophilic aromatic substitution, while subsequent bromination at the 3 and 5 positions is facilitated by the electron-withdrawing nature of the nitro group. This regioselectivity is a hallmark of this compound's synthetic utility, allowing chemists to construct complex aromatic scaffolds with high precision.

In recent years, 1-Bromo-3,5-dimethyl-2-nitrobenzene has found application in the synthesis of biologically active molecules. Its structural features make it a suitable scaffold for designing ligands that interact with specific biological targets. For instance, researchers have explored its use in developing compounds that modulate enzyme activity and receptor binding. The bromine substituents provide handles for further derivatization via cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings, which are pivotal in constructing heterocyclic compounds and amine-containing structures.

One notable area of research involving 1-Bromo-3,5-dimethyl-2-nitrobenzene is in the field of medicinal chemistry. The nitro group can be reduced to an amine, transforming the molecule into a precursor for pharmacophores that exhibit therapeutic potential. Additionally, the dimethyl substitution pattern influences electronic distribution across the aromatic ring, affecting its reactivity and interaction with biological systems. This fine-tuning of structure allows for the optimization of drug-like properties such as solubility, bioavailability, and metabolic stability.

The compound's role in material science is also emerging as a promising avenue for exploration. Its ability to serve as a building block for more complex polymers and coatings has been investigated. The presence of both bromine and nitro groups enables diverse polymerization strategies, including radical-initiated polymerization and controlled/living polymerization techniques. These advancements highlight the compound's versatility beyond traditional pharmaceutical applications.

Recent studies have demonstrated the utility of 1-Bromo-3,5-dimethyl-2-nitrobenzene in catalytic processes. Its derivatives have been employed as ligands in transition metal-catalyzed reactions, enhancing reaction efficiency and selectivity. The electron-deficient nature of the nitro group and the electron-withdrawing effect of bromine make this compound an effective catalyst supporter or co-catalyst in various organic transformations.

The environmental impact of using 1-Bromo-3,5-dimethyl-2-nitrobenzene as an intermediate has also been a subject of interest. While it does not pose significant environmental hazards due to its stable aromatic structure, proper handling and disposal protocols must be followed to minimize ecological impact. Researchers are continually assessing greener synthetic routes to reduce waste and improve sustainability in its production.

In conclusion,1-Bromo-3,5-dimethyl-2-nitrobenzene (CAS No. 78831-77-3) is a multifaceted compound with broad applications in pharmaceuticals, materials science, and catalysis. Its unique structural features enable precise functionalization and integration into complex molecular architectures. As research progresses, new methodologies and applications for this compound are likely to emerge, further solidifying its importance in synthetic chemistry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)